Publication Name	World Journal of Clinical Cases
Manuscript ID	77949
Country	China

Received	2022-06-10 15:43
Peer-Review Started	2022-06-10 15:46
To Make the First Decision
Return for Revision	2022-06-27 09:36
Revised	2022-07-08 17:28
Second Decision	2022-08-23 03:06
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-08-23 16:35
Articles in Press	2022-08-23 16:35
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-08-29 03:44
Publish the Manuscript Online	2022-10-21 02:24

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Bone marrow metastatic neuroendocrine carcinoma with unknown primary site: A case report and review of the literature
Manuscript Source	Unsolicited Manuscript
All Author List	Xue-Bing Shi, Wen-Xia Deng and Feng-Xiang Jin
ORCID	Author(s) ORCID Number Xue-Bing Shi http://orcid.org/0000-0003-1869-7371
Funding Agency and Grant Number
Corresponding Author	Xue-Bing Shi, MD, Attending Doctor, Department of Medical Oncology, Tongling People’s Hospital, No. 468 Bijiashan Road, Tongguan District, Tongling 244000, Anhui Province, China. sxbtlph@163.com
Key Words	Neuroendocrine neoplasm; Bone marrow metastasis; Bone marrow necrosis; Myelofibrosis; Everolimus; Case report
Core Tip	Neuroendocrine carcinoma (NEC) rarely occurs in the bone marrow. We report a patient diagnosed with bone marrow metastatic NEC, bone marrow necrosis and secondary myelofibrosis. As extensive imaging examinations did not show the primary lesion, we speculated that the primary tumor might regress spontaneously or merely not be identified due to lack of positron emission tomography with gallium peptide. Because of the poor general physical condition with an Eastern Cooperative Oncology Group performance status of 3-4, chemotherapy was abandoned, and everolimus as well as the best supportive therapies were given. Unfortunately, the patient’s condition continued to deteriorate and finally passed away.
Publish Date	2022-10-21 02:24
Citation	Shi XB, Deng WX, Jin FX. Bone marrow metastatic neuroendocrine carcinoma with unknown primary site: A case report and review of the literature. World J Clin Cases 2022; 10(30): 11074-11081
URL	https://www.wjgnet.com/2307-8960/full/v10/i30/11074.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i30.11074

Full Article (PDF)	WJCC-10-11074.pdf
Full Article (Word)	WJCC-10-11074.docx
CARE Checklist–2016	77949-CARE-Checklist–2016-revision.doc
Manuscript File	77949_Auto_Edited-LM.docx
Answering Reviewers	77949-Answering reviewers.pdf
Audio Core Tip	77949-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	77949-Conflict-of-interest statement.pdf
Copyright License Agreement	77949-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	77949-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	77949-Language certificate.pdf
Peer-review Report	77949-Peer-review(s).pdf
Scientific Misconduct Check	77949-Bing-Chen YL-2.png
Scientific Editor Work List	77949-Scientific editor work list.pdf
CrossCheck Report	77949-CrossCheck report.pdf